Tag: Carlsmed
COMPaSS personalised spine surgery study begins enrolment
Carlsmed has revealed that the first patients have been enrolled in the COMPaSS study, a multicentre post market prospective observational registry which will collect data...
Carlsmed raises US$30M in Series B funding
Carlsmed recently announced that it has closed an oversubscribed US$30M Series B funding round, which will be used to ramp up commercialisation of aprevo,...
CMS grants transitional pass-through payment for Carlsmed’s aprevo personalised interbody devices
Carlsmed has announced that the Centre for Medicare and Medicaid Services (CMS) has granted its aprevo personalised interbody devices a transitional pass-through (TPT) payment...